MR-Linac Based Prostate SBRT with Simultaneous Integrated Boost to Dominant Index Lesions: Early Results of a Prospective Multicenter Phase II Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S237
DOI: 10.1016/j.ijrobp.2026.06.505 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von M. Quivrin und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Quivrin, M., Martin, E., Baude, J., Bessieres, I., Aubignac, L., Briot, N., Bertaut, A., Crehange, G., Simon, J., & Chargari, C. (2026). MR-Linac Based Prostate SBRT with Simultaneous Integrated Boost to Dominant Index Lesions: Early Results of a Prospective Multicenter Phase II Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S237. https://doi.org/10.1016/j.ijrobp.2026.06.505
Vancouver
Quivrin M, Martin E, Baude J, Bessieres I, Aubignac L, Briot N, et al. MR-Linac Based Prostate SBRT with Simultaneous Integrated Boost to Dominant Index Lesions: Early Results of a Prospective Multicenter Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S237. doi:10.1016/j.ijrobp.2026.06.505
BibTeX
@article{Quivrin2026,
author = {Quivrin, M. and Martin, E. and Baude, J. and Bessieres, I. and Aubignac, L. and Briot, N. and Bertaut, A. and Crehange, G. and Simon, J.M. and Chargari, C.},
title = {MR-Linac Based Prostate SBRT with Simultaneous Integrated Boost to Dominant Index Lesions: Early Results of a Prospective Multicenter Phase II Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S237},
doi = {10.1016/j.ijrobp.2026.06.505}
}
EUVIMED